N-beta-D-Glucopyranosylacetamide | 6983-36-4

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: N-beta-D-Glucopyranosylacetamide
• 英文别名: N-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]acetamide
• CAS: 6983-36-4
• 化学式: C₈H₁₅NO₆
• 分子量: 221.21
• InChiKey: IBONACLSSOLHFU-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  -1.5
• 重原子数：
  15
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.88
• 拓扑面积：
  119
• 氢给体数：
  5
• 氢受体数：
  6

文献信息

• Substituted Imidazole 4-Carboxamides as Cholecystokinin-1 Receptor Modulators
  申请人：Berger Richard

  公开号：US20090118300A1

  公开（公告）日：2009-05-07

  Certain novel substituted imidazole 4-carboxamides are ligands of the human cholecystokinin receptor and, in particular, are selective ligands of the human cholecystokinin-1 receptor (CCK-1R). They are therefore useful for the treatment, control, or prevention of diseases and disorders responsive to the modulation of CCK-1R, such as obesity, and diabetes.

  某些新型取代咪唑4-羧酰胺是人类胆囊收缩素受体的配体，特别是人类胆囊收缩素-1受体（CCK-1R）的选择性配体。因此，它们可用于治疗、控制或预防对CCK-1R调节敏感的疾病和疾病，如肥胖症和糖尿病。
• SUBSTITUTED IMIDAZOLE 4-CARBOXAMIDES AS CHOLECYSTOKININ-1 RECEPTOR MODULATORS
  申请人：Berger Richard

  公开号：US20100311649A1

  公开（公告）日：2010-12-09

  Certain novel substituted imidazole 4-carboxamides are ligands of the human cholecystokinin receptor and, in particular, are selective ligands of the human cholecystokinin-1 receptor (CCK-1R). They are therefore useful for the treatment, control, or prevention of diseases and disorders responsive to the modulation of CCK-1R , such as obesity, and diabetes.

  某些新型取代咪唑-4-羧酰胺是人胆囊收缩素受体的配体，特别是人胆囊收缩素-1受体(CCK-1R)的选择性配体。因此，它们可用于治疗、控制或预防对CCK-1R调节敏感的疾病和障碍，如肥胖和糖尿病。
• Separation Medium for Biochemical Analysis
  申请人：Masuda Mitsutoshi

  公开号：US20090211907A1

  公开（公告）日：2009-08-27

  The invention provides a novel packing composition for separation and/or analysis which permits easy capillary replacement; a process for the production of the packing composition; a method for filling a capillary with the packing composition; and electrophoretic methods (such as capillary electrophoresis) with the same. The invention relates to a packing composition for electrophoretic separation and/or analysis which contains a long self-assembly produced by dissolving a low-molecular-weight amphiphilic compound having a hydrophobic moiety and a hydrophilic moiety in water under heating and then cooling the resulting solution; a process for the production of the packing composition; a method of separation and/or analysis with the composition; and so on.

  本发明提供了一种新型的用于分离和/或分析的填充组合物，可以轻松更换毛细管；生产填充组合物的方法；用填充组合物填充毛细管的方法；以及使用相同的电泳方法（如毛细管电泳）。本发明涉及一种用于电泳分离和/或分析的填充组合物，其包含通过将具有疏水部分和亲水部分的低分子量两亲性化合物在加热水中溶解然后冷却所得的长链自组装体；生产填充组合物的方法；使用该组合物进行分离和/或分析的方法等。
• WASHING OR CLEANING AGENT COMPRISING A HYDROGEL FORMER
  申请人：Henkel AG & Co. KGaA

  公开号：US20140303063A1

  公开（公告）日：2014-10-09

  The invention relates to a washing or cleaning agent, wherein use thereof generates hydrogel layers surfaces, comprising a hydrogel former having a molecular weight less than 3500 g/Mol, wherein the hydrogel former is water-soluble at concentrations below the minimum gel formation concentration, wherein the minimum gel formation concentration is the concentration at which a yield point of at least 0.05 Pa is formed in a binary solution of water and hydrogel former at T=25° C., and wherein said minimum gel formation concentration lies below 2 wt % of hydrogel former, relative to the system consisting of water and hydrogel former. The washing or cleaning agents according to the invention enable the hydrophiliation of surfaces, and the specific and retarded releasing of active substances embedded in the hydrogel layers, such as aromatic substances or antimicrobial active substances, for example.
• US7655611B2
  申请人：——

  公开号：US7655611B2

  公开（公告）日：2010-02-02